BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34404438)

  • 21. A novel laparoscopy-based model for the prediction of optimal cytoreduction and prognosis of epithelial ovarian cancer in a Chinese population.
    Tang X; Zhang X; Liu X; Zheng T; Hua K; Qiu J
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():256-262. PubMed ID: 33259994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combined predictive value of the risk factors influencing the short-term prognosis of sepsis].
    Chen R; Zhou X; Rui Q; Wang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):307-312. PubMed ID: 32385994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer.
    Kim SI; Song M; Hwangbo S; Lee S; Cho U; Kim JH; Lee M; Kim HS; Chung HH; Suh DS; Park T; Song YS
    Cancer Res Treat; 2019 Jul; 51(3):1144-1155. PubMed ID: 30453728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer.
    Chen J; Li Y; Cui H
    Arch Gynecol Obstet; 2021 Mar; 303(3):767-775. PubMed ID: 33011886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study.
    Farolfi A; Scarpi E; Greco F; Bergamini A; Longo L; Pignata S; Casanova C; Cormio G; Bologna A; Orditura M; Zavallone L; Attademo L; Gallà V; Franzese E; Pigozzi E; Loizzi V; Giorda G; Giardina D; Cioffi R; De Giorgi U
    Sci Rep; 2020 Oct; 10(1):18190. PubMed ID: 33097745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
    Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
    Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of antibiotic treatment during platinum chemotherapy on survival and recurrence in women with advanced epithelial ovarian cancer.
    Chambers LM; Kuznicki M; Yao M; Chichura A; Gruner M; Reizes O; Debernardo R; Rose PG; Michener C; Vargas R
    Gynecol Oncol; 2020 Dec; 159(3):699-705. PubMed ID: 32950250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition.
    Yang J; Ma J; Jin Y; Cheng S; Huang S; Zhang N; Wang Y
    Sci Rep; 2021 Mar; 11(1):6540. PubMed ID: 33753862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy.
    Kang J; D'Andrea AD; Kozono D
    J Natl Cancer Inst; 2012 May; 104(9):670-81. PubMed ID: 22505474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.
    Elzarkaa AA; Shaalan W; Elemam D; Mansour H; Melis M; Malik E; Soliman AA
    J Gynecol Oncol; 2018 Jul; 29(4):e47. PubMed ID: 29770618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-treatment prognostic nutritional index is superior to platelet count in predicting disease-specific survival in patients with epithelial ovarian cancer.
    Komura N; Mabuchi S; Yokoi E; Shimura K; Kawano M; Matsumoto Y; Kimura T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1057-1063. PubMed ID: 31203199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
    Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
    Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer.
    Liu CN; Zhang HY
    J Gene Med; 2020 Oct; 22(10):e3233. PubMed ID: 32449981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study.
    Ma J; Yang J; Jin Y; Cheng S; Huang S; Zhang N; Wang Y
    Onco Targets Ther; 2021; 14():3267-3280. PubMed ID: 34040391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
    Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated preoperative plasma D-dimer level is a useful predictor of chemoresistance and poor disease outcome for serous ovarian cancer patients.
    Liu P; Wang Y; Tong L; Xu Y; Zhang W; Guo Z; Ni H
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1163-71. PubMed ID: 26542279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.